Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Novartis
Cipla
Queensland Health
Julphar
Mallinckrodt
Fish and Richardson
Medtronic
Healthtrust
Harvard Business School

Generated: October 20, 2017

DrugPatentWatch Database Preview

GEODON Drug Profile

« Back to Dashboard

Which patents cover Geodon, and when can generic versions of Geodon launch?

Geodon is a drug marketed by Pfizer and Pfizer Inc and is included in three NDAs. There are six patents protecting this drug and one Paragraph IV challenge.

This drug has two hundred and forty-six patent family members in fifty-four countries and two supplementary protection certificates in one country.

The generic ingredient in GEODON is ziprasidone hydrochloride. There are twenty-one drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the ziprasidone hydrochloride profile page.

Summary for Tradename: GEODON

US Patents:6
Applicants:2
NDAs:3
Suppliers / Packagers: see list12
Bulk Api Vendors: see list43
Clinical Trials: see list41
Patent Applications: see list3,468
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GEODON at DailyMed

Pharmacology for Tradename: GEODON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
GEODON
ziprasidone mesylate
INJECTABLE;INTRAMUSCULAR020919-001Jun 21, 2002RXYesYes► Subscribe► Subscribe ► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-002Feb 5, 2001ABRXYesNo► Subscribe► SubscribeY ► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-001Feb 5, 2001ABRXYesYes► Subscribe► Subscribe ► Subscribe
Pfizer Inc
GEODON
ziprasidone hydrochloride
SUSPENSION;ORAL021483-001Mar 29, 2006DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-003Feb 5, 2001ABRXYesNo► Subscribe► Subscribe ► Subscribe
Pfizer Inc
GEODON
ziprasidone hydrochloride
SUSPENSION;ORAL021483-001Mar 29, 2006DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Pfizer
GEODON
ziprasidone mesylate
INJECTABLE;INTRAMUSCULAR020919-001Jun 21, 2002RXYesYes► Subscribe► Subscribe ► Subscribe
Pfizer
GEODON
ziprasidone mesylate
INJECTABLE;INTRAMUSCULAR020919-001Jun 21, 2002RXYesYes► Subscribe► Subscribe ► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-002Feb 5, 2001ABRXYesNo► Subscribe► Subscribe ► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-001Feb 5, 2001ABRXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: GEODON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-003Feb 5, 2001► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone mesylate
INJECTABLE;INTRAMUSCULAR020919-001Jun 21, 2002► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-004Feb 5, 2001► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-001Feb 5, 2001► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone mesylate
INJECTABLE;INTRAMUSCULAR020919-001Jun 21, 2002► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-002Feb 5, 2001► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-003Feb 5, 2001► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-001Feb 5, 2001► Subscribe► Subscribe
Pfizer Inc
GEODON
ziprasidone hydrochloride
SUSPENSION;ORAL021483-001Mar 29, 2006► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-002Feb 5, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for GEODON

Drugname Dosage Strength RLD Submissiondate
ziprasidone hydrochlorideCapsules20 mg, 40 mg, 60 mg and 80 mgGeodon2/7/2005

International Patent Family for Tradename: GEODON

Country Document Number Estimated Expiration
Iceland6134► Subscribe
Poland195209► Subscribe
Malaysia128051► Subscribe
Malaysia121397► Subscribe
Malaysia121036► Subscribe
Bulgaria64475► Subscribe
Australia753820► Subscribe
Japan3942827► Subscribe
Bulgaria102893► Subscribe
Iceland5079► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: GEODON

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2003004Lithuania► SubscribePRODUCT NAME: ZIPRASIDONUM (5-(2-(4-(1,2-BENZIZOTIAZOL-3-IL)-1-PIPERAZINIL)ETIL)-6-CHLOR-1,3-DIHIDRO-2H-INDOL-2-ONAS); REGISTRATION NO/DATE: 02/7887/8 20021002
2003004,C0904273Lithuania► SubscribePRODUCT NAME: ZIPRASIDONUM (5-(2-(4-(1,2-BENZIZOTIAZOL-3-IL)-1-PIPERAZINIL)ETIL)-6-CHLOR-1,3-DIHIDRO-2H-INDOL-2-ONAS); REGISTRATION NO/DATE: 02/7887/8 20021002
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Healthtrust
Deloitte
Moodys
Johnson and Johnson
Citi
Farmers Insurance
Medtronic
Queensland Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot